*Please note some sections maybe blank if no data is relevant
As part of our commitment to continually improve our service and to help our clients meet their legal obligations, we continue to update the Legal Registers on our website and provide free quarterly legal compliance updates to anyone who subscribes. The purpose of these updates is to ensure you stay up to date with any changes in your legal compliance obligations, our updates can also be kept and can be used as evidence that your business is staying up to date with any changes in the legislation, this can be very helpful at audit time.
The Human Medicines Regulations 2012 is a comprehensive regulatory framework governing the authorization, manufacture, distribution, and sale of human medicines in the United Kingdom. Its primary purpose is to safeguard public health by ensuring the safety, quality, and efficacy of medicines available to patients.
Key aspects of the Human Medicines Regulations 2012 include:
The Human Medicines Regulations 2012 apply to a wide range of stakeholders involved in the development, manufacturing, distribution, prescribing, dispensing, and use of human medicines in the UK. This includes pharmaceutical companies, manufacturers, wholesalers, pharmacies, healthcare professionals, clinical researchers, and regulatory authorities. By establishing robust regulatory standards and oversight, the regulations aim to ensure that medicines meet high standards of quality, safety, and efficacy, thereby safeguarding public health and promoting patient safety.
The Human Medicines Regulations 2012 do not explicitly outline evidence requirements in the same manner as legal or law enforcement statutes. However, the regulations establish rigorous standards and procedures for the authorization, manufacture, distribution, and sale of medicines in the United Kingdom. Compliance with these standards often involves the provision and assessment of various types of evidence to ensure the safety, quality, and efficacy of medicines. Key aspects related to evidence requirements under the Human Medicines Regulations 2012 include:
While the Human Medicines Regulations 2012 do not specify evidence requirements explicitly, compliance with regulatory standards typically involves the provision of substantial evidence demonstrating adherence to quality, safety, and efficacy standards throughout the medicinal product lifecycle. Regulatory authorities such as the Medicines and Healthcare products Regulatory Agency (MHRA) rely on this evidence to make informed decisions regarding the authorization and regulation of medicines in the UK, with a primary focus on protecting public health and ensuring patient safety.
The Human Medicines Regulations 2012 establish a comprehensive regulatory framework governing the authorization, manufacture, distribution, and sale of medicines in the United Kingdom. While the regulations do not explicitly outline exemptions, certain provisions and circumstances may result in exceptions or special considerations:
While these exemptions provide flexibility in certain circumstances, they are subject to regulatory controls and oversight to ensure patient safety and the quality of medicinal products. Healthcare professionals, manufacturers, and regulatory authorities must adhere to applicable guidelines and standards to mitigate risks associated with exemptions under the Human Medicines Regulations 2012.
*Please refer to the Terms and Conditions in our footer.
The information contained in this website is for general information purposes only. The information is provided by AvISO, and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is, therefore, strictly at your own risk.
In no event will we be liable for any loss or damage, including, without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website, you are able to link to other websites which are not under the control of AvISO. We have no control over the nature, content, and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, AvISO takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
In addition, the legal texts identified on this website do not represent all the legislation published in relation to the relevant topic areas. AvISO Consultancy selects the legislation which it believes will apply to the organisations and industries with which it is engaged. In addition, there may be some instances where new legislation or amendments to current legislation are introduced, but there is a slight delay between the introduction of that legislation and the availability of it on this website. AvISO Consultancy does not take responsibility for the accuracy of any information provided and would recommend that you take appropriate legal advice in relation to any legislation which is relevant to your organisation, as appropriate. In addition, the content of our webpages does not replace each organisation’s duty to be aware of and comply with the legal requirements applicable to their operations.
Including our quarterly legal compliance updates that are a great resource for evidence for your ISO audits.
If you would like to know more about ISO Standards, Certification and the value of a good management system you can add to your business we would love to hear from you: Kent: 01892 800476 | London: 02037 458 476 | [email protected]